Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.7700
+0.0400 (5.48%)
Aug 3, 2026, 5:35 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €116.12 thousand as of August 3, 2026. Its market cap has decreased by -76.01% in one year.
Market Cap
116.12K
Enterprise Value
248.27K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.77
ChartMarket Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 116.12K, a decrease of -80.65%. That is a compound annual growth rate of -75.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 116.12K | 2,739.74% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| Poxel | 11.26M |
| NFL Biosciences | 11.02M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |
| TME Pharma | 5.89M |
| Plant Advanced Technologies | 5.51M |